For example, increased expression of FUT1 has been associated with increased propensity to metastasize in melanoma and advanced stage in ovarian cancer, while downregulation of FUT1 in a HER2-positive breast cancer cell line decreased proliferation [92–94]. Here, ERBB2 is linked to breast cancer.